Mitochondrial deficiency is associated with insulin resistance
1Division of Endocrinology and Metabolism, Department of Medicine, School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA. bgood@pitt.edu
Diabetes
|March 23, 2013
Summary
Mitochondrial dysfunction, not just reduced energy production, is increasingly linked to insulin resistance (IR). This review explores the complex cellular mechanisms connecting mitochondrial health to metabolic disorders like IR.
Area of Science:
- Cellular Biology
- Metabolic Disorders
- Mitochondrial Function
Background:
- Insulin resistance (IR) mechanisms are not fully understood.
- Mitochondrial capacity for oxidative metabolism is reduced in obesity and type 2 diabetes.
- The causal role of mitochondria in IR remains a subject of debate.
Purpose of the Study:
- To present evidence supporting a causal link between mitochondrial energetics and insulin resistance.
- To explore the multifaceted role of mitochondria beyond energy production in metabolic health.
Main Methods:
- Review of existing literature on mitochondrial function and insulin resistance.
- Analysis of cellular mechanisms connecting mitochondrial derangements to IR.
- Discussion of the relevance of animal models to human IR.
Main Results:
- Mitochondrial derangements can cause IR, but IR does not always involve mitochondria.
- Perturbations in mitochondrial function, beyond energy generation, are critical.
- Mitochondria's diverse functions (signaling, oxidative stress, inflammation) impact IR.
Conclusions:
- Mitochondrial dysfunction is a key factor in the development of insulin resistance.
- The concept of mitochondrial "deficiency" must encompass broader functions beyond energy output.
- Understanding these complex mitochondrial roles is crucial for addressing IR.
Related Concept Videos
Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Diabetes Mellitus: Introduction
Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and long-term...
Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Insulin: The Receptor and Signaling Pathways
Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but this inhibition is released...


